Mark Yan
Impact in
-
- Acute Myeloid Leukemia Research
-
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 1
- Genetics 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Jamie Hirata (2 shared papers)Hervé Tilly (2 shared papers)Franck Morschhauser (2 shared papers)Calvin Lee (2 shared papers)Amitkumar Mehta (1 shared paper)Corinne Haïoun (1 shared paper)Nancy L. Bartlett (1 shared paper)Gilles Salles (1 shared paper)
- Journals
- Blood (4 papers)The Lancet Oncology (1 paper)Leukemia (1 paper)Blood Advances (1 paper)Statistics in Biopharmaceutical Research (1 paper)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Mark Yan
8 papers receiving 150 citations
Peers
Comparison fields: 5 of 27
- Hematology 40
- Oncology 79
- Pathology and Forensic Medicine 50
- Genetics 20
- Immunology 22
Countries citing papers authored by Mark Yan
This map shows the geographic impact of Mark Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Yan more than expected).
Fields of papers citing papers by Mark Yan
This network shows the impact of papers produced by Mark Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Yan. The network helps show where Mark Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 2018 | 25 | |
| 3 | 2021 | 20 | |
| 4 | 2022 | 6 | |
| 5 | 2020 | 2 | |
| 6 | 2019 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2026 | 0 |
About Mark Yan
Mark Yan is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 9 papers that have together received 154 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Mycobacterium research and diagnosis (1 paper), Immunotherapy and Immune Responses (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Hematology (40 citations), Oncology (79 citations), Pathology and Forensic Medicine (50 citations), Genetics (20 citations) and Immunology (22 citations). Mark Yan has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Jamie Hirata, Hervé Tilly, Franck Morschhauser, Calvin Lee, Amitkumar Mehta, Corinne Haïoun, Nancy L. Bartlett, Gilles Salles, Jeff P. Sharman and Javier Muñoz. Their work appears in journals such as Blood, The Lancet Oncology, Leukemia, Blood Advances and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.